6-Hydroxydopamine (6-OHDA) is a neurotoxic compound commonly used to induce dopamine (DA) depletion in the nigrostriatal system, mimicking Parkinson's disease (PD) in animals. The aim of the present study was to evaluate the 7-day effect of unilateral nigral lesion on rat brain monoamine neurochemistry. Five brain regions were examined: the brain stem, cerebellum, hippocampus, striatum, and cortex. 6-OHDA-unilateral lesion dramatically modified DA, serotonin (5-HT) and their metabolites contents in both sides of the different brain nuclei. Furthermore, unilateral 6-OHDA lesion reduced DA and 5-HT contents and produced a robust inversion of their turnover in the nonlesioned side compared to sham-operated rats. These data suggest that 6-OHDA ...
Background Non-motor symptoms (e.g., depression, anxiety, and cognitive deficits) in patients with P...
KEY WORDS subthalamic nucleus; motor thalamic nucleus; electron microscopy; in vivo microdialysis; i...
Rats with 6-hydroxydopamine (6-OHDA)-induced lesions of the substantia nigra are used as a model of ...
Parkinson´s disease(PD) is characterize by a progressive death of dopaminergic neurons in the substa...
Carbon-11 labeled dihydrotetrabenazine (11C-DTBZ) binds to the vesicular monoamine transporter 2 and...
The 6-hydroxydopamine (6-OHDA) lesion of the rat nigrostriatal pathway is the most widely used anima...
PURPOSE: The effect of a highly selective 6-hydroxydopamine (6-OHDA)-induced lesion of the nigrostri...
Despite the progressive development of innovative animal models for Parkinson's disease, the intrace...
Animal models with partial lesions of the dopaminergic nigrostriatal pathway may be useful for devel...
Item does not contain fulltextThe goal of this study was to develop an animal model that evaluates s...
The 6-hydroxydopamine (6-OHDA) model of Parkinson's disease in the rat represents a fundamental tool...
Unilateral injection of the catecholamine neurotoxin 6-hydroxydopamine into the axons or terminals o...
The neurotoxin 6-hydroxydopamine (6-OHDA), following pretreatment with the norepinephrine transport ...
Parkinson´s disease (PD) is characterized by nigro-striatal loss and dopaminergic striatal depletion...
Background: Subthalamic nucleus (STN) neurons undergo changes in their pattern of activity and morph...
Background Non-motor symptoms (e.g., depression, anxiety, and cognitive deficits) in patients with P...
KEY WORDS subthalamic nucleus; motor thalamic nucleus; electron microscopy; in vivo microdialysis; i...
Rats with 6-hydroxydopamine (6-OHDA)-induced lesions of the substantia nigra are used as a model of ...
Parkinson´s disease(PD) is characterize by a progressive death of dopaminergic neurons in the substa...
Carbon-11 labeled dihydrotetrabenazine (11C-DTBZ) binds to the vesicular monoamine transporter 2 and...
The 6-hydroxydopamine (6-OHDA) lesion of the rat nigrostriatal pathway is the most widely used anima...
PURPOSE: The effect of a highly selective 6-hydroxydopamine (6-OHDA)-induced lesion of the nigrostri...
Despite the progressive development of innovative animal models for Parkinson's disease, the intrace...
Animal models with partial lesions of the dopaminergic nigrostriatal pathway may be useful for devel...
Item does not contain fulltextThe goal of this study was to develop an animal model that evaluates s...
The 6-hydroxydopamine (6-OHDA) model of Parkinson's disease in the rat represents a fundamental tool...
Unilateral injection of the catecholamine neurotoxin 6-hydroxydopamine into the axons or terminals o...
The neurotoxin 6-hydroxydopamine (6-OHDA), following pretreatment with the norepinephrine transport ...
Parkinson´s disease (PD) is characterized by nigro-striatal loss and dopaminergic striatal depletion...
Background: Subthalamic nucleus (STN) neurons undergo changes in their pattern of activity and morph...
Background Non-motor symptoms (e.g., depression, anxiety, and cognitive deficits) in patients with P...
KEY WORDS subthalamic nucleus; motor thalamic nucleus; electron microscopy; in vivo microdialysis; i...
Rats with 6-hydroxydopamine (6-OHDA)-induced lesions of the substantia nigra are used as a model of ...